To determine the effect of urologist and radiologist learning curves and changes in MRI-TRUS fusion platform during 9 years of NCI’s experience with multiparametric magnetic resonance imaging ...

Targeted MRI–transrectal ultrasonography (MRI–TRUS) fusion biopsy is emerging as a powerful new technique to more accurately diagnose clinically significant prostate cancer. A recent study comparing ...

In a study, 8.8% of clinically relevant prostate cancers detected by systematic biopsy were missed by MRI-targeted biopsy. In men with prostate lesions visible on multiparametric magnetic resonance ...

Here's welcome news for men of a certain age: new results support a less invasive approach to investigations for suspicion of prostate cancer. An approach using MRI of the prostate followed by ...

Results from the phase 3 PRECISE trial showed that MRI with targeted biopsies matched or exceeded the accuracy of the current standard for detecting clinically significant prostate cancer. The current ...